mRNA cancer vaccines market projected to reach $113 billion by 2028
Summary: The mRNA cancer vaccines and therapeutics market is projected to grow from $52.85 billion in 2023 to $61.52 billion in 2024, with a compound annual growth rate of 16.4%. By 2028, the market could reach $113.41 billion.
This growth is driven by increased funding for medical research, favorable regulations, and advancements in treatment technologies. Key trends include personalized medicine, multivalent vaccines, and improved mRNA delivery systems.
North America was the largest market in 2023, while Asia Pacific is expected to grow the fastest. Major companies in this field include Pfizer, Merck, and Moderna, focusing on innovative mRNA cancer treatments.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings